Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
October 2002
Features
Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease
Replacement of hormones after menopause can be tricky for women who already have heart disease.
Kimberly Braxton Lloyd, PharmD, Kirsten Fanning, PharmD, CGP, and Lisa Boothby, PharmD
Management of Ischemic Stroke in Geriatric Patients
The authors summarize new strategies for preventing and treating stroke in older patients.
Charles T. Taylor, PharmD, BCPS, Pamela Stamm, PharmD, Kelly H. Taylor, PharmD, and Kristi Kelley, PharmD
Current Pharmacological Treatment Options for Prostate Cancer
Several new treatment options are available for men with prostate cancer.
Kirsten D. Fanning, PharmD, CGP, and Kimberly Braxton Lloyd, PharmD
Bisphosphonates for the Prevention and Treatment of Osteoporosis
Bisphosphonates play an important role in the treatment of osteoporosis.
Lisa Anne Boothby, PharmD
CME
Advances in the Treatment of Dementia
The authors present a comprehensive review of Alzheimer’s disease and related dementias.
Michael Lewko, MD, CMD, Elyas Safar, MD, and Richard Birrer, MD, MPH, FACP, FAGS
Departments
Editorial
The Hospital Room of the Future
Editor-in-Chief David Nash discusses how technology may soon revolutionize a patient’s hospital experience.
David B. Nash, MD, MBA
Drug News
New Drugs/Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Prescription Washington
PBM Skeptics Surfacing in the Senate
Mr. Barlas discusses the Senate’s perceptions of problems with PBMs.
Stephen Barlas
Medication Errors
The “Five Rights”
Professionals who prescribe medications must understand the “five rights.”
Matthew Grissinger
Drug Forecast
Frovatriptan Succinate (Frova™)
The authors review the latest triptan (frovatriptan) for the treatment of acute migraine.
Evans Branch III, PharmD, Marlon Honeywell, PharmD, Erika Slater, Pharm D Candidate, Daryl Norwood, PharmD, and Letitia Coleman, PharmD Candidate
